Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) EBT Margin (2016 - 2025)

Apyx Medical's EBT Margin history spans 15 years, with the latest figure at 5.98% for Q4 2025.

  • For Q4 2025, EBT Margin rose 4342.0% year-over-year to 5.98%; the TTM value through Dec 2025 reached 20.5%, up 3305.0%, while the annual FY2025 figure was 20.5%, 3305.0% up from the prior year.
  • EBT Margin reached 5.98% in Q4 2025 per APYX's latest filing, up from 14.58% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 5.98% in Q4 2025 to a low of 73.57% in Q1 2024.
  • Average EBT Margin over 5 years is 41.11%, with a median of 45.31% recorded in 2022.
  • Peak YoY movement for EBT Margin: soared 10876bps in 2021, then tumbled -4678bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 11.15% in 2021, then crashed by -321bps to 46.9% in 2022, then crashed by -39bps to 65.05% in 2023, then rose by 24bps to 49.4% in 2024, then soared by 88bps to 5.98% in 2025.
  • Per Business Quant, the three most recent readings for APYX's EBT Margin are 5.98% (Q4 2025), 14.58% (Q3 2025), and 32.44% (Q2 2025).